Skip to main content
. 2019 Nov 5;9:1161. doi: 10.3389/fonc.2019.01161

Figure 3.

Figure 3

Forest plot of association between TMB and progression-free survival of immune checkpoint inhibitors. HR, hazard ratio; CI, confidence interval; TMB, tumor mutation burden.